Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hepatocellular carcinoma, intestinal disorder, liver disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pancreatic adenocarcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 1 / Phase 2	2026-01-13		NCT05651022

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Indaptus Therapeutics, Inc	1
Translational Drug Development	3

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Atlantic Health System	Morristown	United States	17
Cleveland Clinic Taussig Cancer Center	Cleveland	United States	16
Fox Chase Cancer Center	Philadelphia	United States	259
Gabrail Cancer & Research Center	Canton	United States	6
Hoag Memorial Hospital Presbyterian	Newport Beach	United States	66
Prisma Health Cancer Institute-ITOR	Greenville	United States	1
Roswell Park Comprehensive Cancer Center	Buffalo	United States	63
The Barbara Ann Karmanos Cancer Institute	Detroit	United States	2
UH Seidman Cancer Center	Cleveland	United States	3
University of Southern California- Norris Cancer Center	Los Angeles	United States	1
Washington University, Siteman Cancer Center	St Louis	United States	2
Winship Cancer Institute of Emory University	Atlanta	United States	45